Following a lengthy regulatory procedure and clinical study, the World Health Organization (WHO) authorized the R21/Matrix-M vaccine last year, finding it to be both highly effective and reasonably priced. A major advancement in halting the spread of the mosquito-borne illness might be made possible by the low-dose vaccines ability to be manufactured rapidly and in large quantities.   ..Read More